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ABSTRACT 
This thesis is the result of clinical studies carried out in Northern Tanzania from 1984-1992 and 
reports on a number of new clinical entities. These are HIV related neurological disorders, 
konzo and new forms of existing diseases such as Guillain-Barre Syndrome (GBS). The first 
and second papers report that neurological disorders were amongst the most common (70%) 
disorder in AIDS. The Snout and Palmomental reflexes were the most common abnormal 
neurological finding and increased incrementally with advancing HIV stage and associated 
neurological disorders. The third paper investigates a consecutive series of GBS cases admitted 
to Kilimanjaro Christian Medical Centre (KCMC) and to Haukeland University hospital 
Western Norway and demonstrated that the incidence rate, epidemiological and main clinical 
fmdings apart from minor differences were similar in the two series. The increased mortality 
rate (15%) seen in the Tanzanian series is explained mainly by the lack of resources for 
adequate intensive care. An association between HIV infection and GBS was seen in the 
Tanzanian but not the Norwegian series and HIV positive GBS patients tended to have more 
severe neurological disease and increased mortality. The fourth and fifth papers are reports on 
field surveys in Tarime district in Northern Tanzania investigating an epidemic of unexplained 
spastic paraparesis which occurred in 1985. The studies showed that the disease is a distinct 
entity manifested by spastic paraparesis and characterized by a disorder which always affects 
the distal upper motor neurones to a greater extent than the proximal ones. The disease was 
named konzo, a local name from the first reported outbreak in Zaire (Trolli 1938). The 
prevalence of konzo in 15 villages studied ranged from zero cases in the lake shore villages to 
1411000 in the inland villages only 5 km away. All patients gave a history of almost complete 
reliance on bitter cassava as a staple food in the months prior to and during the epidemic. This 
arose because of the widespread failure of other crops as a result of the severe drought in 1984. 
In addition the traditional processing methods used for removal of cyanogenic compounds from 
the roots of bitter cassava appeared to have been shortened. A resulting high cyanide exposure 
was supported by high serum thiocyanate levels, the mean SCN in May 1985 in 20 cases and 9 
controls were 368 and 303 flmoles/l respectively. The geographic and temporal distribution of 
konzo was also shown to be compatible with cyanide exposure from insufficiently processed 
cassava roots and there was no evidence of an infectious aetiology. The sixth paper reports on 
specialized neurological investigations of two patients with konzo who were brought to Sweden 
which suggests that the site of the pathology in konzo is most probably situated centrally in the 
motor cortex rather than in the spinal cord. 
Keywords: Africa; Tanzania: Norway; Sweden: HIV; AIDS; Neurological disorders; 
Snout; Palmomental; Reflexes; Guillain Barn'! syndrome; Konzo; Spastic paraparesis: 
upper motor neurone disorder; Cyanide; Thiocyanate; Cassava; Motor cortex. 
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4. INTRODUCTION 
Neurological disorders are an important cause of morbidity and mortality in sub-Saharan Africa 
but a large percentage of patients with such disorders never get to hospital (Tekle-Haimanot 
1990). In spite of this, neurological disorders may account for up to 10% of medical admissions 
to referral hospitals (Billinghurst 1987). However, they are frequently under-diagnosed or 
misdiagnosed because of inadequate clinical training and the unavailability of diagnostic 
resources. Only a few specialized centers in Africa have access to modern diagnostic facilities. 
In the vast majority of African hospitals neurological diagnoses remain a matter of clinical 
judgment alone. 
While a large part of neurological diseases in Africa are similar to those in the West there are 
some striking differences which are due to special environmental, genetic, and socioeconomic 
factors (Spillane 1973). In this thesis I use the term Africa to mean sub-Saharan Africa and the 
West as a handy designation for the most affluent or industrialized countries. Infections of the 
nervous system like cerebral malaria, sleeping sickness, tetanus and meningococcal meningitis 
are all common in African countries whereas they do not occur at all or are relatively 
uncommon in developed countries. Paralysis of the legs is several times more common in 
Africa because of leprosy, polio, tuberculosis and trauma. In contrast, neurodegenerative 
disorders such as Alzheimers dementia, Parkinsons disease, as well as multiple sclerosis are all 
uncommon or may not occur at all in African countries. 
The African pattern of neurological disorders is also changing over time. During the last 
decades infections such as syphilis, sleeping sickness, polio and leprosy have decreased. In the 
same period new neurological disorders have been identified in Africa. These include human 
immunodeficiency viruses (HIV -1 and HIV -2) associated neurological disorders (Mukuyandela 
and Mweindapole 1987, Clavel et ai, 1987, Amayo et ai, 1988, Belec et ai, 1989, Klemm et aI, 
1988, Kayembe et al, 1989), Human T cell-Lymphotropic Virus type I (HTL V -I) associated 
myelopathy also known as HAM (Gessain et al, 1985, 1986) and also an epidemic form of 
spastic paraparesis associated with consumption of insufficiently processed cassava (Ministry of 
Health Mozambique 1984a). The most alarming new development in African neurology is 
without doubt the neurological disorders resulting from the rapid dissemination of HIV. WHO 
estimates that there are now more than 10 million persons infected in sub-Saharan Africa. 
Tanzania is among the worst HIV affected countries in Africa with an estimated one million 
persons HIV infected out of a total population of 27 millions. The life expectancy in Tanzania is 
approximately 54 years and adult literacy rates approach 90%. Tanzania has a gross national 
product in the order of 160 US dollars per person which is among the lowest in the world. In 
spite of this it has a national comprehensive health service although its function is hampered by 
severe economic constraints. There are only two specialized neurologists for the entire country 
both of whom are based at Muhimbili Medical Center in Dar es Salaam. There are no facilities 
for computerized tomography (Cn or magnetic resonance imaging (MRJ) and Tanzania has 
only one functioning electroencephalograph machine. 
From 1984 to 1992 it was my privilege to work for the Ministry of Health (MoH) of Tanzania 
in Kilimanjaro Christian Medical Center (KCMC) Moshi in the northern zone of this country. 
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KCMC is one of the four consultant hospitals in Tanzania and serves as a referral center for 
over 6 million people. The hospital is situated in the beautiful setting of the foot hills of Mount 
Kilimanjaro ("see cover"). 
The present thesis is based on 8 years work as a general physician in the medical department at 
KCMC. Among my tasks was to be consultant neurologist for northern Tanzania from 1984 to 
1992 during which time I examined over 2000 referred neurological patients. This thesis reports 
on three neurological disorders which appeared for the first time or in a new form during this 
period (Fig 1). The fust two papers are reports on neurological findings in a large series ofHIV 
positive and negative patients from the catchment area of KCMC. The third paper is a 
comparative study based on a consecutive series of GBS cases admitted to KCMC and to 
Haukeland hospital, University of Bergen, Western Norway. The fourth and fifth papers are 
reports on field surveys in Northern Tanzania investigating an epidemic of unexplained spastic 
paraparesis which occurred in 1985. This upper motor neurone disorder was identified as a 
distinct disease entity and named konzo, a local name from the first reported outbreak in Zaire 
(Trolli 1938). The sixth paper reports specialized neurological investigations of two patients 
with konzo. The background information for these three clinical conditions is reviewed in the 
following sections. 
4.1. Neurological disorders in HIV disease 
Retroviruses were known to be pathogenic to animals but infections in man were not recognized 
until 1980 when HTL V -I was isolated from a patient with cutaneous T -cell lymphoma (Poiesz 
et ai, 1980) and later in patients with T -cell leukaemia (Hinuma et ai, 1981, Miyoshi et ai, 
1981). Although a new form of immunodeficiency was first recognized as a clinical entity in the 
United States in 1981 (Gottlieb et ai, 1981) the link between immunodeficiency, AIDS and 
retrovirus infection was not made until 1983 when human immunodeficiency virus type 1 
(HIV -1) was isolated from a patient with generalized lymphadenopathy (Barre-Sinoussi et ai, 
1983). In 1985 evidence of a second human immunodeficiency virus (HIV -2) was identified 
from West Africa (Barin et ai, 1985). 
Neurological disorders are now recognized as frequent manifestations of infection with HIV-I 
occurring in over 40% of AIDS patients in the West (Rowen and Came 1991). However early 
reports on AIDS in Africa suggested that neurological disorders were much less common there 
(Odio 1985, Mukuyandela and Mweindapole 1987, Amayo et ai, 1988, Belec et ai, 1989, 
Luambeya et aI, 1989, Kayembe et ai, 1989). Neurological disorders are also known to occur in 
HIV-2, but the frequency is unknown (ClaveI1987, Rubsamen-Waigmann et al, 1987, Hugon et 
ai, 1988, Klemm 1988, Livrozet et ai, 1990). 
Neurological disorders in HIV infection can be categorized into three main groups, A) disorders 
of the central nervous system caused by primary HIV infection, B) disorders caused by 
secondary mainly opportunistic processes and C) disorders affecting the peripheral nervous 
system and muscle. These disorders may occur at seroconversion, in the long asymptomatic 
stage, or more commonly during the symptomatic stages of AIDS related complex (ARC) and 
AIDS. 
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Neurological disorders occurring at seroconversion include encephalopathy, meningItIS, 
. myelopathy and neuropathy, (Came et ai, 1985, Piette et al, 1986, Denning et al, 1987, Wiselka 
et ai, 1987, McArthur and 10hnson 1988). These neurological manifestations associated with 
primary HIV infection are relatively uncommon and usually self limiting and tend to go 
unrecognized in Africa despite the high incidence of HIV infection there. Inflammatory 
neuropathies, including Guillain-Barre syndrome and Bells palsy were among the first HIV 
related neurological disorders to be reported in Africa (Conlon 1989, Thornton et ai, 1991) 
occurring mainly in the asymptomatic stage. Herpes zoster infection also occurs mainly in 
asymptomatic HIV infection and often provides the first clinical clue as to the presence of 
underlying HIV infection in this continent (Kestelyn et al, 1987, Colebunders et ai, 1988, Van 
de Perre et al, 1988, Katabira et ai, 1989, Nkya et ai, 1989, Thornton and Latif 1989). Major 
focal and non focal neurological disorders tend to occur in ARC or in AIDS and are the group 
most frequently reported in clinical studies on AIDS from Africa (Mukuyandela and 
Mweindapole 1987, Amayo et ai, 1988, Belec et al, 1989, Kayembe et ai, 1989, Thomton et al, 
1989). Most major neurological disorders occur as a result of opportunistic processes but 
definitive microbial and pathological confirmation is mostly missing in Africa. 
4.1.1. Aids dementia complex 
AIDS dementia complex is amongst the most frequently reported neurological disorders 
encountered in AIDS in the West affecting one to two thirds of patients (Navia et ai, 1986, 
Gabusda et ai, 1987, Price et al, 1988, 1992) although recent studies suggest a somewhat lower 
overall prevalence rate (Portegies et al 1993). In contrast ADC is frequently not reported at all in 
the African continent or at a much lower rate (Belec et ai, 1989, Kayembe et ai, 1989). ADC is 
characterized by disturbances of cognition, motor performance and behaviour and usually 
becomes clinically apparent in late AIDS. The pathogenesis of ADC has not been established 
but there is evidence that ADC may be the result of direct HIV infection of the brain via 
infected macrophage and microglial cells. The staging of ADC is based on clinical findings 
(Price et ai, 1992). However, the diagnosis is also heavily dependent on the exclusion of 
opporturllstic processes by neuroimaging. A mild elevation in protein and mononuclear cells in 
the CSF seen in some patients is non diagnostic. The neuroimaging features of ADC include 
widened cortical sulci, enlargement of the ventricals and subcortical white matter abnormalities. 
The main histopathological abnormalities comprise of subcortical HIV specific encephalitis 
characterized by widespread mUltiple foci of multinucleated giant cells and diffuse white matter 
changes called leukoencephalopathy (Budka 1991). A substantial loss of cortical neurons and 
synapses (Ketzler et ai, 1990, Everall et ai, 1991) particularly in the frontal lobes has also been 
reported in AIDS and ADC. Associated abnormal neurological findings include tremor, ataxia, 
pyramidal tract signs, distal neuropathy and frontal lobe release signs (FLRS) (Price et ai, 
1992). At the start of the present study there were no reports of ADC in AIDS in Africa. 
4.1.2. Frontal lobe release signs 
The snout reflex (SR) and palmomental (PMR) reflexes belong to a group that are called 
primitive, developmental or foetal reflexes (Kugelberg 1952, Paulson and Gottlieb 1968). They 
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may also be classified as frontal lobe release signs (FLRS). They include other well known 
reflexes such as the grasp reflex, glabellar tap, sucking reflex and the jaw jerk. FLRS are 
normally present during the development of the foetal nervous system but are suppressed as the 
brain matures. They may reappear when the higher centers in the central nervous system (CNS) 
cease to function or have been altered by disease or old age. They are found more commonly in 
advanced bilateral diffuse cortical disease than in corresponding unilateral disease states 
(Tweedy et aI, 1982, De Renzi and Barberri 1992) and particularly in frontal lobe disease as the 
name implies. The choice of anyone of these reflexes in a study is somewhat arbitrary as there 
are interrelationships and clinical overlap between the individual reflexes. 
The SR was first observed in children in 1898 while investigating the Chvostek phenomenon 
(Escherich 1898) and in adults in 1903 (Bechterew 1903). It was defmed more clearly in 1903 
(Toulouse and Vurpas 1903). The PMR was first described in 1920 in a patient with extensive 
corticobulbar disease due to amyotrophic lateral sclerosis (Marinesco and Radovici 1920). The 
SR and PMR are the earliest foetal developmental reflexes (Bieber 1940, Paulson and Gottlieb 
1968) and the SR has in the past been considered to be the labial component of the sucking 
reflex. The SR and PMR have been described mainly in association with specific CNS diseases. 
These include dementia, Parkinson's disease, frontal lobe disease, cerebral arteriosclerosis, 
stroke, amyotrophic lateral sclerosis, pseudobulbar palsy, hydrocephalus and other conditions 
(Blake and Knukle 1951, Ekbom et al, 1952, Bracha 1958, Reis 1961, Ansink 1962, Paulson & 
Gottlieb 1968, Jenkyn et ai, 1977, Gossman and Jacobs 1980, Jacobs and Gossman 1980, Marx 
and Reschop 1980, Tweedy et al, 1982, de Noordhout and Delwaide 1988). Very rarely these 
reflexes are unobtainable because of a break in the reflex arc, i.e. in Bell's palsy. 
The SR and PMR are generally regarded as soft neurological signs because of their lack of 
specificity in the absence of other localizing neurological signs and the fact that they can be 
found in the normal subjects, with a higher frequency in infancy and in old age (Kugelberg 
1952, Ekbom 1952, Jacobs and Gossman 1980, Whittle and Millar 1987, de Noorhout and 
Delwaide 1988). Indeed many neurologists doubt their clinical usefulness particularly in the 
face of widespread availability of modem neuroradiological facilities (Whittle and Millar 1987). 
FLRS were first described in association with AIDS in 1986. (Navia et aI, 1986). In that report 
they were reported to be present in 38% of patients with advanced ADC. Since that report the 
SR and grasp reflexes have been described as common in ADC (Gabuzda et aI, 1987, Navia et 
aI, 1987, Price et aI, 1988, Price et aI, 1992). At the time of the present study there were no 
published studies of FLRS in African patients with HIV disease and no detailed study of their 
frequency in the different stages of the disease. 
4.1.3. Opportunistic processes 
Opportunistic infections and tumours in the CNS are known to be the main cause of major focal 
and non focal neurological disorders in HIV disease (Dix et aI, 1988, Pons et al, 1988, So et aI, 
1988). Their diagnosis in Africa relies mainly on inference from advanced clinical and autopsy 
studies carried out in the West and more recently a few similar studies in Africa (Lucas et aI, 
1988). Toxoplasmosis, tuberculosis and cryptococcal meningitis were recognized early on as 
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the main CNS opportunistic infections in AIDS in Africa (Clumeck et ai, 1984, Odio et al, 
1985, Lucas et ai, 1988, Nelson 1990). 
Toxoplasma gondii is an intracellular protozoan parasite frequently found in humans. 
Serological evidence suggests that more than 20% of adults in African populations have been 
exposed to primary infection with Toxoplasma (WHO 1984, Clercq et ai, 1986). It is the main 
opportunistic infection in the brain affecting between 20 to 40% of AIDS in the West (Navia et 
al, 1986, Luft and Hafner, 1990). The first report of this infection from Africa came from a 
postmortem series in Uganda where 23% of AIDS cases had cerebral toxoplasmosis (Lucas et 
ai, 1988). Features strongly suggestive of cerebral toxoplasmosis were also present in early 
clinical studies from Africa (Thimossat 1987, Belec et al, 1989). Cerebral toxoplasmosis 
presents mainly as headache and fever, usually in combination with the onset of a focal 
neurological disorder occurring over weeks but occasionally within days. Confusion and coma 
may also occur, particularly in late cases. 
The laboratory diagnosis of active toxoplasmosis infection is considered unreliable (Grant et ai, 
1990). The CSF may only show a nonspecific increase in Iymphocytes and protein although 
occasionally serological studies may disclose a diagnostic high antibody titre, or a rise in titre. 
Neuroimaging is the most sensitive investigation, however, other opportunistic processes such 
as tumours can give an appearance similar to toxoplasmosis. A definitive diagnosis can only be 
obtained by brain biopsy but in practice the diagnosis mostly relies on clinical suspicion and a 
therapeutic response to empirical treatment (Cohn et ai, 1989). 
Mycobacterium tuberculosis (TB) and Mycobacterium avium-intracellulare (MAl) both cause 
CNS infection in AIDS . In Africa TB is the main opportunistic infection in AIDS, affecting 
more than 50% of terminal cases (Colebunders et ai, 1989, Nelson 1990). Reactivation oflatent 
mycobacteria, thought to exist in as many as 60% of adult Africans is considered to be the main 
mechanism of TB infection in HIV disease. In the West TB affecting the CNS in HlV infection 
has been described mainly in immigrants and IV drug users. In one series of 14 HlV positive 
patients with CNS tuberculosis the main clinical presentations were multiple brain abscesses, 
meningitis, grand mal seizures, headaches, meningism and alteration in mental state (Levy et ai, 
1988). Despite the high prevalence of TB there were no clinical reports of TB affecting the 
CNS in AIDS in Africa at the time when this study was initiated. 
Cryptococcal meningitis was one of the first CNS opportunistic infections to be reported in 
AIDS in Africans (Clumeck et ai, 1984, Desmet et ai, 1989, Belec et ai, 1989, Testa et ai, 1989). 
These early studies suggested geographical variation in the prevalence of cryptococcal 
meningitis. The prevalence was highest in Central Africa where environmental exposure to the 
causative organism seems to be high (Desmet et ai, 1989). Clinical features of cryptococcal 
meningitis include slow onset of fever, headache, photophobia and malaise, often over a period 
of several weeks. Vomiting, neck stiffness and confusion are usually late manifestations (Chuck 
and Sande, 1989). The diagnosis is often prompted by the presence of meningeal symptoms and 
signs, but they may also be absent. A definitive diagnosis can be made in 70 to 80% of AIDS 
patients by examining the CSF with India ink and demonstrating the presence of capsular 
yeasts. The CSF Iymphocytes counts and protein levels may be slightly elevated and glucose 
levels normal or decreased. Cryptococcal antigen can be demonstrated in 95% of cases (Desmet 
et ai, 1989). 
13 
Herpes zoster occurs in HIV infection due to reactivation of latent varicella-zoster infection. 
The HIV epidemic in Africa has resulted in a 20 fold increase in zoster incidence rates in some 
hospitals in Africa (Colebunders et aI, 1988, Van de Perre et al, 1988, Katabira et al, 1989). 
Herpes zoster affects between 5 to 10% of HIV infected persons and is one of the earliest and 
distinctive clinical disorders seen in HIV infection in Africa. It is typically multi dermatomal, 
locally aggressive and leaves a very characteristic residual hyperpigmented scar occasionally 
with keloid formation. Complications include post herpetic corneal scarring and neuralgia and 
rarely encephalitis, stroke and radiculitis (Kestelyn et al, 1987, Thornton and Latif 1990). 
Cytomegalovirus (CMV) infection is common worldwide. High rates of infection are also 
reported in Tanzania where most adult persons seem to have corresponding antibodies (Mhalu 
and Haukenes 1990). Chorioretinitis is the most common ocular opportunistic infection in 
AIDS in the West (Holland and Kreiger 1988). Neurological manifestations related to CMV 
infection include encephalitis and radiculitis, but these are uncommon. At the time of the 
present studies there were no reports of CMV infection in HIV disease in Africa. 
In the West other viral, bacterial and protozoal infections are known to affect the nervous 
system in HIV disease. These include progressive multifocalleukoencephalopathy (PML) due 
to human papovavirus and encephalitis due to herpes simplex viruses, but at the time of this 
study there were no reports from Africa for comparison. Infection with Treponema pallidum is 
relatively common in Africa but the overall prevalence of neurosyphilis is low, probably due to 
the widespread use of penicillin. Apparently the natural history of neurosyphilis can be altered 
by co-infection with HIV (Johns et aI, 1987). However there are few reports on neurosyphilis 
and HIV infection (Hook 1989) including only one from Africa (Thornton et aI, 1989). Also 
there are only isolated reports in Africa of bacterial meningitis in HIV infection (Gilks et al, 
1990). It should be noted that several infectious diseases in Africa affect the nervous system 
apparently without any defmite association with HIV infection. This is the case with malaria, 
leprosy, trypanosomiasis, schistosomiasis and many others. 
Tumours in the CNS may be associated with HIV infection. These include primary lymphoma, 
systemic non-Hodgkins lymphoma and metastatic Kaposi's sarcoma (Bayley, 1988, So et aI, 
1988). These tumours are relatively uncommon and in Africa are mostly reported as incidental 
postmortem findings (Lucas et ai, 1988). The clinical presentation is typically one of 
progressive focal neurological deficits similar to toxoplasmosis, but the symptomatic evolution 
is slower. Their accurate diagnosis depends mostly on neuroimaging. 
4.1.4. Peripheral nerve disorders 
HIV is associated with a wide range of complications affecting the peripheral nerves, nerve 
roots and muscles. These complications are amongst the most frequent neurological disorders in 
HIV infection and vary in nature and frequency with the stage of the disease (Cornblath et ai, 
1987, de la Monte et ai, 1988, Leger et al, 1989, Millar et al, 1988, Parry 1988). The most 
common neuropathy is a distal sensory polyneuropathy which may affect as many as a third of 
terminal AIDS patients (Cornblath 1988). Inflammatory polyneuropathies and 
mononeuropathies, may also occur during or soon after seroconversion and also in the 
asymptomatic stage of HIV infection (przedborski et al, 1988, Cornblath et ai, 1987). They 
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include Guillain-Barre syndrome (GBS), chronic inflammatory demyelinating polyneuropathy 
(CIDR) and mononeuritis, most commonly Bells palsy. Disorders of muscle range from 
polymyositis, occurring mainly in HIV infection, to a myopathy in symptomatic HIV disease 
and in AIDS. At the start of the present study there were few reports on neurological disorders 
in HIV disease in Africa and none on peripheral nerve disorders. 
4.2. Guillain-Barre Syndrome 
Guillain-Barre Syndrome (GBS) is an illness causing progressive weakness of the limbs with 
diminished or absent reflexes due to polyradiculoneuropathy in the absence of a recognized 
cause. Such an illness was fIrst described by Landry in 1859. In 1916, Guillain, Barre and Strohl 
described the albumin-cytological dissociation which is characteristic of'GBS and they gave the 
disease its name (Hughes 1990a). The pathological basis of GBS is now regarded to be an 
immune mediated inflammatory polyneuropathy (Hartung HP 1993). 
GBS is known to occur worldwide with average yearly incidence rates in the range of 1-2 cases 
per 100,000 population (Alter 1990, Hughes 1990b). GBS was once considered to be rare in 
persons of African origin (Haymaker and Kernohan 1949) and the incidence rate in adults in 
sub-Saharan Africa is still not known. There are few detailed descriptions of GBS from sub-
Saharan Africa apart from studies in Nigeria (Osuntokun and Agbebi 1973) and in Kenya 
(Bahemuka 1988). Those studies suggest that the frequency and clinical fIndings in GBS in 
Africa are generally similar to those found in the West. The onset of GBS is in most cases 
associated with an antecedent triggering event, most commonly infection, but it may also be 
associated with a recent vaccination or trauma. 
An association between primary and latent HIV infection and inflammatory polyneuropathies 
was found early on in the epidemic in the West (Piette et al, 1986, Berger et ai, 1987, Cornblath 
et ai, 1987, Dalakas and Pezeshkpour 1988). In those studies inflammatory polyneuropathies 
were described at or around the time of seroconversion, in flSymptomatic HIV infection as well 
as occasionally in AIDS. The clinical presentation was similar to non HIV associated 
inflammatory polyneuropathies but a distinguishing feature was presence of increased 
lymphocyte count in the CSF in the HIV seropositives. This was reported as a mean 23 cells/ml 
in one series (Cornblath et ai, 1987). The outcome was favourable in most cases although a 
variable and fulminating course has also been reported (Dalakas and Pezeshkpour 1988). At the 
time of the present study there were no published reports of GBS in HIV in Africa and no 
information on GBS in Tanzania. 
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4.3. Tropical Myeloneuropathies 
The tenn "tropical myeloneuropathies" was used to describe a group of obscure paraparesis of 
unknown aetiology by Roman et aI, (1985). They distinguish two main clinical groups. First 
tropical spastic paraparesis, a mainly spastic paraplegia with minimal or no sensory signs, and 
second tropical ataxic neuropathy (TAN) which is a mainly sensory fonn of ataxia combined 
with peripheral neuropathy. The causes of many fonns of paraparesis in the tropics were 
obscure for decades but gradually several distinct etiological and clinical entities have been 
distinguished from this group of tropical myeloneuropathies. 
4.3.1. Lathyrism 
Lathyrism is an epidemic fonn of acute spastic paraparesis found exclusively in parts of India, 
Bangladesh, Ethiopia and nowadays South East Asia where large quantities of the chick pea 
(Lathyrus sativus) a drought resistant crop are grown and consumed (Ludolph et aI, 1987). It 
has been causally linked to a neuroexitatory amino acid in the chick pea, beta-N-oxalylamino-L-
alanine (Spencer et aI, 1986). The association with chick pea was already recognized in ancient 
Greece (Acton 1922) and the same cause was claimed earlier this century in Southern Europe 
(Gardner and Sakiewicz 1963). The reports of lathyrism to date in Africa have all been confined 
to areas of Ethiopia which seems to be the only part of that continent where chick pea is 
presently grown and consumed (Tekle-Haimanot 1990). 
4.3.2. HAM 
HTL V -I associated myelopathy (HAM) was distinguished as a separate entity following the 
discovery in 1985 of HTL V -1 antibodies in two patients with spastic paraparesis in Martinique 
(Gessain et aI, 1985). This was quickly followed by the discovery of HTL V -1 antibodies in 
patients with the same type of spastic paraparesis throughout the Caribbean (Rodgers-Johnson 
et aI, 1988), South America, (Zaninovic et aI, 1988), the Seychelles (Roman et aI, 1987) as well 
as in West Indian born UK residents (Newton et aI, 1987). In Japan Osame et al (1987) used the 
tenn HAM for the first time to describe a chronic progressive myelopathy in six patients who 
had high serum and CSF HTL V -1 antibody titres. This disorder which affects mainly older or 
middle aged persons, is characterized by a gradual onset of a progressive fonn of spastic 
paraparesis associated with sphincteric disturbances and usually some sensory loss. A causal 
relationship between HTLV-I and HAM was definitely established in 1990 when a cardiac 
transplantation recipient developed HAM within a year of receiving HTL V -I infected blood 
(Gout et al, 1990). ' 
The first reports of HTLV-I associated myelopathy (HAM) in Africans were made in 
expatriates living in Europe. (Gessain et aI, 1986, 1993, Ryberg et aI, 1987. Gout et aI, 1989). In 
one of the first studies in Africa, 3 out of 26 cases of spastic paraparesis reported from the Ivory 
Coast were clinically and immunologically identical to HAM (de The' et al, 1989). Since then a 
number of reports of HAM have come from Africa. An endemic cluster of 23 cases out of a 
total of 32 patients with spastic paraparesis was reported from a village in Northern Zaire 
(Kayembe et aI, 1990). Another report involved 24 cases of HAM out of 36 cases of 
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unexplained myelopathy in a referral hospital in the province of Natal in South Africa (Bhigjee 
et aI, 1990). Similarly, in Zimbabwe three out of 5 cases of spastic paraparesis were diagnosed 
. as HAM (Houston et aI, 1994). While the identification of HT LV-I antibodies in a number of 
patients with unexplained tropical myeloneuropathies in Africa represents a major advance in 
our understanding of these disorders. HTL V -I still accounts for only a relatively small 
proportion ofmyeloneuropathy cases seen in Africa (Tyleskar 1994). 
4.3.3. Konzo 
An epidemic form of acute spastic paraparesis was first described by Trolli (1938), an Italian 
physician working in the Bundundu region in the former Belgian Congo (Trolli 1938). His 
report describes over 1000 cases occurring in 1936-37 in this cassava growing region of modem 
day Zaire. He also mentioned similar epidemics in the same region in 1932 and 1928 and 
possibly even earlier. He used the local name for the disease "konzo" in his report. The clinical 
similarity to lathyrism was noted at the time, but as no Lathyrus sativus was grown or 
consumed in the area an infectious cause or a toxico-nutritional effect related to cyanide 
intoxication from insufficiently processed cassava was proposed. Fourteen years later Lucasse 
reported the same cases (Lucasse 1952) unaware of Trolli's publication. New epidemics 
occurred again in Zaire in 1978 and 1983 (CEPLANUT 1982, WHO 1982, Kasela 1983). 
In 1981 an epidemic of over 1000 cases of spastic paraparesis occurred apparently for the first 
time in East Africa in a cassava growing region in Mozambique (Ministry of Health 
Mozambique 1984a, 1984b). The clinical description was of a symmetrical spastic paraparesis 
with an abrupt onset affecting mainly children and young adults. That epidemic was attributed 
to a high dietary cyanide intake from insufficiently processed cassava and also a dietary 
deficiency of sulphur containing amino acids (Cliff et aI, 1985). At the time of the present 
studies there were limited clinical descriptions of this epidemic form of spastic paraparesis and 
it was unclear if it was to be regarded as a separate entity. There was no information as to the 
site of the lesion in the CNS and the theories on aetiology were conflicting. In 1986 Carton 
described a similar disease in the Bundundu Region of Zaire (Carton et aI, 1986). He found it to 
be identical to the epidemic spastic paraparesis from Mozambique but he suggested an 
infectious cause rather than the cyanide hypothesis put forward from the Mozambique studies. 
4.3.4. TAN 
Tropical ataxic neuropathy (TAN) is another form of tropical myeJoneuropathy which occurs in 
Africa. An epidemic form of ataxic polyneuropathy or peripheral neuritis was first described in 
sugar cane workers in the West Indies at the end of the last century and early in this century 
(Strachan 1888, 1897, Scott 1918). The main clinical features were painful sensory symptoms 
in the feet, areflexia, ataxia, optic neuritis and skin signs of avitaminosis. A similar pellagra-
like disease was reported from Africa (Stannus 1936) and in Europe where residual upper motor 
signs were first noted in some prisoners of war (Fisher 1955). The occurrence of these disorders 
were linked to malnutrition, as patients responded to vitamin B supplementation or a change in 
diet. In 1930 Moore reported an association between optic neuritis, avitaminosis and a high 
cassava diet in boarding school boys in Nigeria. Their symptoms improved with a change in 
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diet. The tenn tropical ataxic neuropathy (TAN) was first used in Nigeria (Osuntokun 1968) to 
describe an almost similar disease in a cassava eating population. The clinical picture was 
characterized by a gradual onset of ataxia in older adults in combination with peripheral 
neuropathy, optic atrophy, nerve deafness and sometimes spastic paraparesis. The presence of 
any two of these clinical features was sufficient to establish a clinical diagnosis. Similar clinical 
features were described in patients in Tanzania (Haddock et aI, 1962, Makene and Wilson 
1972). TAN was also attributed to eN exposure from cassava although it is clinically and 
epidemiologically different from epidemic spastic paraparesis. Other possible dietary factors 
including vitamin B deficiency were considered to play a role in the disease. Since that time no 
further cases ofT AN have been reported in Nigeria or Tanzania. 
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5. AIMS OF THE PRESENT STUDY 
1. To describe the main neurological findings in AIDS and HIV disease and the natural history 
of Frontal lobe release signs in HIV disease in Northern Tanzania (papers I,ll). 
2. To describe the clinical and epidemiological findings in Guillain Bam~ syndrome in Northern 
Tanzania in comparison to such cases in Western Norway with special emphasis on the role of 
HIV (paper Ill). 
3. To describe the clinical, epidemiological and laboratory findings in an epidemic of 
unexplained spastic paraparesis which was named konzo (paper IV), and to determine its 
temporal and geographic distribution (paper V) and the site and character of the neurological 
lesion in this disease (paper VI). 
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6. REVIEW OF PAPERS 
Paper I. Neurological findings in mv infected persons in Tanzania. 
To study the occurrence of AIDS associated neurological disorders in Tanzania a total of 200 
consecutive cases of AIDS admitted to the medical department at KCMC from March 1985 to 
June 1988 were examined by the author. History was obtained in English or Kiswahili or by 
translation when appropriate from the local languages, Kichagga, Kimeru, Kipare, Kimasai and 
others. The results showed that 21 out of 200 (10.5%) had an obvious focal neurological 
disorder. These included cranial nerve palsies (5), involuntary movements (4), hemiparesis (3), 
paraparesis (3), seizures (3), hemianopia (1), cerebellar ataxia (1) and hemianesthesia (1). A 
detailed neurological examination was carried out on the last 135 AIDS patients and on 53 HIV 
seronegative controls. The controls comprised of inpatients hospitalized for a variety of chronic 
non neurological conditions and were comparable in age, sex and tribe. Ninety-seven out of 135 
(72%) had less obviously detectable neurological abnormalities, versus 36% of controls (p< 
0.005). The most frequent abnormal neurological fmdings in AIDS were ADC (54%), 
retinopathy (23%), areflexia (21%), pyramidal tract signs (19%) and ataxia (19%). On 
examination for the presence of FLRS, the SR and PMR were found to be present in 76% of 
AIDS patients versus 36% in controls (p<0.005). AIDS patients with advanced and terminal 
disease were more likely to have neurological disorders than were AIDS patients in the earlier 
stage. A further study on 87 patients presenting only with acute neurological disorders showed 
10 out of 87 (11.5%) to be HIV positive, (three case studies are presented). These HIV related 
disorders included Guillain Barn~ syndrome (5), hemiplegia (I), encephalitis (1), space 
occupying lesion (1), epilepsy (1) and Bells palsy 1. The results of this paper suggest that in 
Tanzania, neurological disorders are common in AIDS. They are also associated with 
otherwise asymptomatic HIV infection. 
Paper 11. FLRS in HIV infected persons in Tanzania. 
The aim was to study the relationship of the SR and PMR in HIV infected persons. Between 
1987-92 the presence of these reflexes were recorded by the author in a series of 1127 adults, 
649 HIV seropositive and 478 HIV seronegative, from 4 groups in Northern Tanzania at 
different risk for HIV infection. The respective prevalences were analyzed in a model 
controlling for sex, age and stage by multiregression analysis. In the total series the prevalences 
of SR was 65% and PMR 49% in the HIV seropositives, versus SR 19% and PMR 15% in the 
HIV seronegative reference group. Similar associations were observed, although somewhat 
weaker in each of the groups (II-IY) which were assumed to be less exposed to HIV infection. 
In the HIV seropositive group there was a clear increase in the prevalence FLRS with advancing 
HIV stage. The results ranged from SR 39% and PMR 23% in asymptomatic HIV infection to 
SR 87% and PMR 69% in terminal AIDS. The prevalence of SR and PMR increased 
significantly with age in HIV seronegatives, but not in seropositives. The SR and PMR were 
also independently associated with ADC, distal polyneuritis and pyramidal tract signs 
independent of HIV stage, but not with herpes zoster and retinopathy. FLRS in advanced and 
terminal AIDS were the most obvious and easiest to elicit. This study showed a strong 
20 
association between the SR and PMR and HIV disease and associated neurological disorders in 
Tanzania. 
Paper Ill. GBS in Northern Tanzania and Western Norway. 
The aims of this paper were to compare the clinical and epidemiological fmdings in GBS 
patients in Tanzania and Norway. The patients were selected from consecutive neurological 
admissions to the medical wards at KCMC from 1984 to 1992 and similarly from the 
nevrological department of Haukeland hospital, Bergen, from 1980 to 1992. The records of 
patients with a diagnosis of GBS aged 12 or older were retrospectively evaluated. Using the 
NINCDS criteria (Asbury 1990) a consecutive series of 59 patients in Northern Tanzania and 56 
in Western Norway were identified as cases of GBS. A total of 45 out of the 59 patients in the 
Tanzanian series came from the Kilimanjaro region and here the average annual incidence rate 
was found to be 0.83 cases per 100,000. In Western Norway the corresponding incidence rate in 
an earlier study was 1.2 cases per 100,000 (Larson et ai, 1985). The results of HIV testing was 
available for 36 out of the 59 GBS patients in the Tanzanian series, eleven of whom (31 %) were 
HIV seropositive. None of the patients in the Norwegian series were HIV seropositive. 
A significantly greater number of GBS in the Tanzanian series occurred in the second 4 year 
period of the study. There was a seasonal preference for the coldest months of the year in the 
Norwegian but not in the Tanzanian series. Comparing the two series, GBS patients in the 
Tanzanian series had less antecedent infection 41% vs 66% (p<0.001), and there was a longer 
time interval from onset of neurological symptoms to hospital admission, 19 vs 8 days 
(p<0.001), and a longer duration in hospital 76 vs 42 days (p< 0.01). On neurological 
examination the GBS patients in the Tanzanian series compared to the Norwegian series 
presented with, less upper extremity involvement, less motor weakness 49% vs 75% (p<0.01) 
and less sensory disturbance 19% vs 45% (p<0.0 1). On the other hand urinary retention, 15% vs 
4% (p<0.05) and elevated CSF protein, 204 versus 112 mg% (P<0.05), were more frequent in 
the Tanzanian series. The overall mortality was significantly greater in the Tanzanian than in 
the Norwegian series, 15% versus 2% (p<0.01). 
HIV infection was significantly more frequent in the Tanzanian GBS patients (11/36, 31 %) as 
compared to (16114687, 3.4%) (p<0.001) found in blood donors from Northern Tanzania. The 
HIV seropositive GBS patients in comparison with the seronegative GBS patients presented 
with more, upper limb involvement 82% vs 40% (p<0.05), and cranial nerve paralysis 64% vs 
12% (p<O.OI). They also had a higher mortality 46% vs 16% (p= 0.07). In conclusion, although 
the main findings were generally similar there were some differences in clinical presentation 
and mortality rate between the two series. HIV infection was associated with GBS in the 
Tanzanian series and led to a poorer prognosis. 
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Paper IV. Konzo epidemic. 
The main aim was to elucidate the character and cause of an outbreak of unexplained 
paraparesis which had occurred for the first time in early 1985 in some villages in the Tarime 
district located in the Western part of the Mara region of Northern Tanzania. Following a 
request from the local authorities in the Mara region, a survey was carried out by the author in 
April, May, and June in three villages known to be most affected. The staff at the local hospital, 
village leaders and health care workers identified the patients who had developed paralysis of 
the legs during the previous year. The criterion for inclusion as a case, was onset of difficulty in 
walking during the previous year due to paralysis of the legs in the absence of any other well 
defined neurological disease. A total of 39 cases (30 males and 9 females) were identified and 
these formed the study group. The case histories were obtained through interviews in the local 
Luo language by a medical assistant. Dietary information was obtained by observations and 
open interviews with family heads and village leaders. A blood sample was taken for serum 
thiocyanate SCN and HTL V -I analysis from each patient and 9 of hislher non affected family 
members. Follow up examinations were carried out on 20 patients in May and June 1985, on 
15 patients in March 1986 and again on 10 patients in May 1988. 
The overall prevalence in the three villages surveyed was 3.811000. No case was reported from 
nearby fishing villages along Lake Victoria or in the district capital or the adjacent highlands. 
The patients were primarily males in the age group 3-19 years and also women in the 
childbearing years. Eleven out of 39 cases gave a history of a previous attack of the same 
disease prior to 1984. Many families had more than one affected member with almost half the 
cases coming from 6 families. A total of 73% of the onsets occurred between February and 
April 1985. The uniform history in all cases was of an abrupt onset of a symmetrical spastic 
paraparesis usually first noticed on waking or walking. Progression to peak weakness occurred 
over an average of2-3 days. Clinical investigation also showed evidence ofhyperreflexia in the 
upper limbs in 56% of cases. Functional involvement of the upper limbs was generally absent or 
limited to the dorsal extensors, except in the most severely affected cases when it was more 
generalized. Optic neuritis was found in 6/8 patients with difficulties seeing, and impaired gag 
reflex in 2 patients with dysarthria. Examinations after 3 years confirmed that all persons with 
konzo remained with the same degree of spastic paraparesis in flexion and a scissors gait. 
All patients gave a history of a drought induced almost complete reliance on bitter cassava as a 
staple food in the months prior to and during the epidemic. In addition the traditional processing 
methods used for removal of cyanogenic compounds from the roots of bitter cassava appeared 
to have been shortened. A resulting high cyanide exposure was supported by high serum 
thiocyanate levels. Mean SCN in May 1985 in 20 cases and 9 controls were 368 and 303 
mmolesll respectively. In June and July 1985 the levels had decreased to 256 and 184 mmoles 
respectively. 
The clinical findings and associations with cassava toxicity were almost identical to outbreaks 
in Mozambique (Ministry of Health 1984a), and the so called "konzo "outbreak in Zaire (Trolli 
1938). It is concluded that konzo constitutes a distinct upper motor neuron disease entity 
probably caused by a toxic effect from insufficiently processed cassava under adverse dietary 
conditions 
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Paper V. Konzo distribution 
The aim was to study the temporal and geographic distribution of konzo with reference to the 
proposed toxico-nutritional or infectious aetiology. In April 1989 using the same methods as in 
the previous study a total of 15 villages in the northern part of Tarime district were surveyed 
over a 2 week period. All subjects with a neurological cause of locomotor difficulties were 
examined and a clinical neurological diagnosis was made. The criteria used for a diagnosis of 
konzo were: (1) The presence of a visible symmetrical spastic abnormality of gait and/or 
running; (2) a history of distinct onset in time in a previously healthy person; (3) non 
progression; and (4) the presence of bilaterally exaggerated tendon reflexes in the legs. A total 
of 116 cases of konzo were identified. In addition 91 cases of neurological disorders other than 
konzo were identified and clinical fmdings presented. 
The prevalence of konzo in the 15 villages ranged from zero cases in the lake shore villages to 
1411000 in the inland villages, only 5 km away, confirming the observations in the earlier study 
in 1985. The first cases of konzo in 1979 coincided with the introduction of new drought 
tolerant high yielding bitter cassava varieties. A total of 62% of cases occurred in 1985 during 
the main epidemic but a low endemicity was present each year since 1985 despite normal 
rainfall. All cases had a uniform clinical picture of isolated, non progressive, spastic paraparesis 
identical to findings in earlier studies. Of the 116 konzo patients examined 14% had a visible 
spastic gait only on running, 53% had a clear spastic gait, but did not require sticks, 19% 
required one stick to walk, 9% used 2 sticks and a further 5% were unable to stand. The main 
outcome of the study was that the geographic and temporal distribution of konzo were 
compatible with the proposed dietary aetiology of cyanide exposure from insufficiently 
processed cassava roots. Other toxico-nutritional factors may be involved. The possibility of 
HTL V -infection had been excluded in an earlier study, and the complete absence of cases from 
the fishing villages close by the high prevalence villages makes an infectious aetiology less 
likely. 
Paper VI. Site and character of the lesion in konzo. 
The aim was to localize the site and neurological character of the lesion in konzo. With the 
approval of the ethical committees of the Ministry of Health of Tanzania and of the Uppsala 
University two male patients with moderately severe konzo were invited to Sweden in October 
1991 for advanced investigations. They had onset of konzo in 1985 during the epidemic in the 
Tarime district when both had high serum SCN levels indicating high dietary cyanide exposure. 
Histories and detailed neurological examinations were repeated in Sweden. Magnetic 
Resonance Imaging of the brain and spinal cord was performed with a Philips T5 MR scanner 
without use of intravenous contrast. The following neurophysiological investigations were 
carried out: electroencephalography, electromyography at rest and during contraction, motor 
and sensory peripheral nerve conduction studies, somatosensory, visual and brain stem evoked 
potentials, transcranial magnetic stimulation of the motor cortex and cervical cord, pure-tone 
audiometry and conventional caloric tests and electronystagmography and conventional 
ophthalmological investigations. Hematological, serological and CSF investigations were also 
carried out including attempts to isolate retroviruses. 
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MRI imaging, peripheral nerve conduction studies and EMG were completely normal in both 
patients. However motor evoked potentials on magnetic brain stimulation were abnormal. 
Surprisingly there was a complete absence of response not only in the legs in both patients and 
also in the arms which were only slightly clinically affected. There were also signs of central 
visual field defects in one patient who had a history of optic neuritis. The results of the 
laboratory investigations showed no evidence of an infectious agent. It is concluded that konzo 
is a distinct disease entity with a very selective type of upper motor neuron damage that is 
compatible with a toxico-nutritional etiology. 
24 
7. DISCUSSION 
The main scientific contribution of this thesis is the detailed clinical description of a number of 
apparently new clinical entities in northern Tanzania. These include HIV related neurological 
disorders, konzo and new forms of GBS. These disorders are a reflection of the recent dramatic 
change in the pattern of neurological disease not only in Tanzania, but throughout sub-Saharan 
Africa. The work presented is primarily based on the clinical observations of one physician and 
therefore must reflect the inherent weaknesses of this type of research. The individual 
investigations are reasonably representative of the respective study populations particularly with 
regard to gender, age and ethnic group. The studies involved both hospital and community 
based approaches, both of which are needed in modern clinical research in Africa. Access to 
patients was probably not a major determinant in any of the studies as health services in 
Tanzania are free. KCMC itself is a large teaching hospital and is supported by the excellent 
laboratory facilities at the Northern Zonal Reference Center for Parasitic and Infectious 
Diseases. The Kilimanjaro region is fairly densely populated and is renowned for its good 
infrastructure, health services and communication network. Another important factor in the 
studies was the stability of political, social and health services in Tanzania relative to several 
other countries in Africa. In particular the well structured administrative divisions allowed ready 
and long term access to patients and the relevant census data. 
7.1. Neurological findings in RIV Disease. 
Neurological disorders had previously been considered to be uncommon in AIDS in Africa, or 
at most only about 10% of patients (Arnayo et ai, 1988, Beloc et ai, 1989, Mukuyandela and 
Mweindapole 1987). Our results from Tanzania shows that at least in this part of Africa the 
burden of abnormal neurological findings is generally similar to findings in AIDS in the West 
(Levy et ai, 1988, Rowen and Came 1991). This conclusion is supported by recent similarly 
detailed studies from Central and West Africa (Perries et ai, 1992, Kouassi et ai, 1993) where 
neurological disorders were found in over 40% of AIDS patients. An association between 
neurological disorders and otherwise asymptomatic HIV infection in Tanzania (Paper I) was 
also shown in West Africa (Kouassi et ai, 1993). In the present as well as previous studies in 
Africa major neurological disorders were found in over 10% of AIDS patients. In contrast the 
less obvious but more common abnormal neurological findings in AIDS (paper I, Perries et ai, 
1992, Kouassi et ai, 1993) appears to have been overlooked in most other studies in Africa. 
In the West most major neurological disorders in AIDS occur as a result of opportunistic 
processes (Rowen and Came 1991, Koppel 1992). The results of the present study and other 
reports suggest a similar pattern in Africa (Beloc et ai, 1989, 1993, Girdano et ai, 1990, Perries 
et ai, 1992). However the lack of neuroimaging, biopsy and autopsies in Africa has up to now 
precluded precise correlation of neurological findings with underlying opportunistic processes. 
Despite this obvious limitation a working diagnosis may frequently be possible allowing some 
patients to be treated empirically. · 
Autopsies were fundamental to the early clinical descriptions of AIDS in the West (Reichert et 
ai, 1983, Moskowitz et ai, 1983). The early autopsy studies in Uganda (Lucas et ai, 1988), in 
Cote d'Ivoire (Abouya et ai, 1992), and Zaire (Nelson 1990), reported selected patients and, 
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except for the study by Lucas et al, without commenting on the brain. However the publication 
of a recent major autopsy series of HIV positive deaths from Abijan, Cote d'Ivoire provided 
missing vital information on the role of opportunistic disease in AIDS on the African continent 
(Lucas et ai, 1993). In that series opportunistic infections accounted for 85% of the main clinical 
manifestations with two or more opportunistic infections being present in over half of the cases. 
Toxoplasmosis, tuberculosis and cryptococcal meningitis were the main opportunistic processes 
in the CNS. 
Toxoplasmosis. 
Clinical features suggestive of cerebral toxoplasmosis were present, but not etiologically 
confirmed in about 10% of the cases in the present as well as in other main clinical studies in 
Africa. More recently, a study from Cote d'Ivoire using modern neuroinvestigative techniques 
confirmed cerebral toxoplasmosis to be the major opportunistic CNS infection in AIDS, 
affecting 37% of 78 AIDS neurological patients (Kouassi et al, 1993). In the major autopsy 
series from Cote d'Ivoire cerebral toxoplasmosis was shown to be present in 15% of AIDS 
patients, and to be the third most common cause of death after tuberculosis and bacteremia 
(Lucas et ai, 1993). In that same study cerebral toxoplasmosis was also shown to correlate 
closely with a defined cerebral lesion before death. These studies suggest that toxoplasmosis 
may also be a major opportunistic infection in other parts of Africa. However the differing 
seroprevalence rates of Toxoplasma infection reported from Africa (WHO 1984, Thimossat 
1985, Clercq et ai, 1986) shows that there may be variations in the prevalence of cerebral 
toxoplasmosis within the continent. 
Tuberculosis (TB). 
In the present study definite evidence of TB was found in only II % of our AIDS patients and 
evidence involving the CNS was found only in 0.5% of these cases. It is likely however that TB 
was considerably under-diagnosed, mainly because of lack of Xray equipment. TB involving 
the CNS in HIV disease has been rarely reported in Africa despite the fact that the prevalence of 
TB of the lungs in such groups may range from 11-40% (Colebunders et ai, 1991, De Cock et al 
1992). Clinical presentations include meningitis and brain abscess (Thornton et al, 1989, 
Colebunders et aI, 1989, Gilks et al, 90, Nelson et al, 90). TB of the lungs was confirmed in 
38% of all cases, and in 54% of those dying with AIDS in the autopsy series in Cote d'Ivoire 
(Lucas et ai, 1993). In the same study evidence of tuberculous meningitis was reported in 11% 
cases of terminal AIDS and in 20% of all patients with proven TB. Patients diagnosed as 
tuberculous meningitis had a significantly higher median CD4+ T-Iymphocyte count than those 
without meningitis but with TB. This report from Cote d'Ivoire suggests that patients with 
tuberculous meningitis may present at an earlier stage of HIV disease. This was the first study to 
report a high incidence of CNS related TB in HIV infection in Africa. A similar high frequency 
of TB meningitis has also been reported in Spain (Berenguer 1992), but not elsewhere. 
Tuberculomas were found in only 1 % of autopsy cases in Cote d'Ivoire suggesting that mass 
lesions due to TB may be uncommon in that part of Africa. Similarly, although the spinal cords 
were not examined, clinically suspected spinal compression due to tuberculosis was present in 
only one patient in that series. Tuberculous involvement of the CNS in HIV disease, in 
particular meningitis, appears to have been underestimated in Africa up to now, but its diagnosis 
clearly depends on a high degree of clinical suspicion. 
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Cryptococcoses. 
Clinical evidence suggestive of cryptococcal meningitis was present in a small number of 
patients in the present study. Although laboratory evidence of crytococcal infection was not 
looked for at the time, serological investigations carried out later on stored sera suggest an 
overall prevalence rate of 2 to 3% (non published observation). A similar low prevalence rate 
(3%) was seen in the autopsy series from Cote d'Ivoire (Lucas et aI, 1993). Other clinical and 
autopsy studies from this region have reported prevalence rates of cryptococcal meningitis in 
HIV infected patients between 3 and 13% (Clercq et al, 1986, Desmet et aI, 1989, Pierriens et 
aI, 1992, Belec et al, 1993) which probably reflect regional variation of prevalence of this 
infection. 
Varicella-zoster. 
Herpes zoster (HZ) scarring was present in 6.5% of our AIDS patients in this study. This agrees 
with the rate of 6% recorded previously in a HIV positive high risk group in Northern Tanzania 
(Nkya et aI, 1989), but is higher than a rate of 4% reported at autopsy in Cote d'Ivoire (Lucas et 
aI, 1993) and lower than the 11 % observed in symptomatic outpatients in Uganda (Katabira et 
aI, 1989). Thus, as may be expected there appears to be some regional variation in the 
prevalence of HZ in HIV disease within Africa. There were no neurological complications in 
the present study apart from post herpetic neuralgia which occurred in about 10% of cases. 
AIDS dementia complex. 
AIDS dementia complex was reported in 54% of the AIDS patients in this study. A similar high 
frequency of ADC had been reported in the West (Navia et al, 1986, Price et al, 1988), although 
recent studies suggest that the true figure may be somewhat lower (Portegies et aI, 1993). The 
overall frequency of ADC reported in Africa varies from only 1 % in Cote d'Ivoire (Kouassi et 
aI, 1993),3.3% in Central African Republic (Belec et aI, 1989), and 12.5% in Zaire (Perries et 
aI, 1992). It has been suggested that the prevalence of ADC in HIV disease is particularly low in 
Africa because of shortened survival, also the finding of HIV specific neuropathological 
findings in only 2% of autopsied cases in Cote d,Ivoire would seem to support this (Lucas et aI, 
1993). However this suggestion has not been confirmed by the fmdings in the present study or 
the study from Zaire (Perries et al 1992). 
The high frequency of ADC, reported in our study may be related to diagnostic criteria. 
Evidence for this can be seen from the high prevalence of psychomotor retardation (24%) 
reported in our study. Psychomotor retardation is the very earliest stage of ADC (Price et al 
1992) and is not mentioned in the other studies on ADC from Africa, apart from Zaire (Perries 
et al 1992). In that study psychomotor retardation was present in 20% of AIDS patients but was 
always in association with cognitive impairment. Evidence of cognitive impairment was present 
in 19% of AIDS patients in our study, a result which compares favorably with the frequency in 
Zaire and a recent study in the West (Portegies et ai, 1993). 
Another major factor in ADC in Africa is the inability to distinguish between cognitive changes 
caused by direct HIV encephalopathy from those resulting from secondary opportunistic 
processes. This is likely to contribute to a false positive diagnosis and suggests that the true 
prevalence of ADC in AIDS in Africa may be lower than that presently reported. 
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Abnormal motor findings frequently accompany ADC (Price et ai, 1988). In our study almost 
three out of four AIDS patients had abnormal neurological fmdings on detailed examination. 
These included FLRS, tremor, ataxia, hyperreflexia, and extensor plantar response, distal 
neuropathy, and retinopathy. These findings were more common in advanced than in the early 
AIDS cases and generally agree with the results from Zaire (Perries et ai, 1992). In that study 
the frequency of pyramidal tract signs were 19% and tremor 32%. The frequency of distal 
polyneuritis was, however, only 3% as compared to 21 % in our study. However the presence of 
decreased or absent reflexes were not commented on in the Zairian study. Similarly signs of 
retinopathy were not commented on in the Zairian study although they were reported in 23% of 
the AIDS patients in our study. Only 2% of our patients had typical features of cytomegalovirus 
(CMV) retinitis. A similar frequency was reported at autopsy in Cote d'Ivoire (Lucas 1993), 
suggesting that disseminated CMV infection may be less frequent in AIDS in Africa. 
7.2. FLRS in IIIV disease. 
Although FLRS in HIV disease are known to be associated with advanced AIDS and ADC in 
the West (Price et ai, 1988), this is the first study from Africa to show that the SR and PMR 
were strongly associated with progressive HIV disease and its related neurological disorders. 
Recently a positive SR has been included as a criteria for the earliest stage of ADC (Price et al 
1992). FLRS, the grasp reflex (5%), SR (2%), and PMR (38%) were also reported in a study 
involving 42 patients with advanced AIDS from West Africa (Perries et al 1992). However 
. there was no information concerning the methodology, patient population, HIV stage or 
controls in this or the other studies on FLRS in HIV infection. Thus, the present study is the first 
to give these details in HIV infection. 
Differences in methodology for eliciting, grading and recording FLRS was considered to be the 
major reason for the wide variation in prevalence rates seen in similar CNS disease states in the 
past (Blake and Knukle 1951, Reis 1961, Ansink 1962, Paulson & Gottlieb 1968, Jenkyn et al 
1977, Jacobs and Gossrnan 1980, Marx and Reschop 1980, Whittle and Millar 1986). This may 
also explain the differences reported in HIV disease. These methodological problems are in turn 
related to the techniques, instruments, sites, strength and type of stimulus used, and in particular 
testing for habituation or repeatability. Other non neurological factors apart from age may 
influence the SR and PMR. The state of an individual's excitement (Marx and Reschop 1980), 
as well as the use of drugs such as phenothiazine, alcohol and anoxia may transiently increase 
the frequency of positive reflexes (Bracha 1958). Clearance of positive FLRS with 
improvement in the underlying CNS disease state has also been known to occur (Whittle and 
MilIar 1987). These associations may be important to control for in future studies in HIV 
disease. FLRS may be demonstrated electrophysiologically in 100% of normal people 
depending on the type and strength of stimulus used (Ekbom et ai, 1952, Kugelberg 1952, 
Girlanda et ai, 1986, Caccia et al, 1991) but the corresponding rates of clinical detection are 
usually much lower. 
The importance ofFLRS in HIV disease appears to have been underestimated up to now. Quite 
apart from their role in understanding the pathophysiology of HIV related CNS disorders they 
provide a physical sign which may be useful in monitoring HIV disease. Although the 
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pathophysiology ofFLRS is not understood they are probably related to the widespread cortical 
and subcortical damage in the brain which occurs as a result of direct HIV infection (Dunlop et 
aI, 1993, Jernigan et aI, 1993, Masliah et aI, 1992, Ketzler et aI, 1990, Everall et aI, 1991 , 
McArthur et aI, 1990). Recommended criteria for standardizing examining techniques in any 
future studies on FLRS in HIV disease should include, 1) the methodologies outlined in paper 
11, 2) screening for habituation or repeatability of positive FLRS five times before considering a 
reflex to be positive, 3) the use of an independent observer and or modern e1ectrophysiological 
methods to confirm results, 4) the use of laboratory methods eg CD4 counts, in addition to the 
clinical staging of HIV infection. 
7.3. GBS. 
The main epidemiological and clinical features of GBS in Tanzania and Norway were 
remarkably similar, allowing for the differences in age distribution and in resources between the 
two countries. The incidence rate in the Kilimanjaro region also agrees with the world wide 
figure of one or two cases per 100,000 population (Hughes 1990b, Alter 1990). This is the first 
report on GBS incidence rate in adults in sub-Saharan Africa, although similar a similar rate has 
been reported before in North Africa (Radhakrishnan et aI, 1987) and in children in South 
Africa (Kibel 1983). It is reasonable to suppose that most clinical cases of this acute or subacute 
disease occurring during the study period in the Kilimanjaro region were referred to KCMC. 
The compiled evidence then suggests that GBS in Africa is similar to other parts of the world. 
The role of antecedent events was apparent in both series, and seasonality was seen in the 
Norwegian but not the Tanzanian series. A similar slight increase in the frequency of GBS 
during the colder months of the year has already been reported in an earlier study from 
Hordaland county (Larsen et aI, 1985) and is most likely explained by an increased incidence of 
mainly viral infections predisposing to GBS. However seasonality alone is not considered 
sufficient to significantly affect overall incidence rates of GBS (Alter 1990). 
The main clinical features of GBS in the Tanzanian series were similar to the other main studies 
in Africa (Osuntokun and Agbebi 1973, Bahemuka 1988). By comparison with the Norwegian 
series there were delays from onset to hospital admission and a prolongation of hospital stay in 
the African studies. This is hardly surprising given the obvious lack of resources for admission 
and discharge which exist in most hospitals in developing countries. There were also some 
differences in clinical findings including a tendency for more sphincter and lower limb 
involvement and less sensory involvement in the Tanzanian series. Whether these differences 
are real or a function of other factors such as methodology or case selection is not known but 
similar fmdings have been reported in the other main studies on GBS in Africa. 
The mortality rate in GBS in our study was increased by comparison with the Norwegian series 
and is higher than corresponding rates reported from Nigeria (6%), and Kenya (11 %). It is likely 
that these reported rates from Africa are an underestimate, as deaths occurring during the period 
prior to hospitalization are likely to have been missed. Mortality rates similar to that reported in 
the Tanzanian series were frequent in the West before the introduction of intensive respiratory 
and cardiac care (Haymaker and Kemohan 1949). The much lower rate (2%) seen in the 
Norwegian series agrees with the best data from other specialized centers in the West (Loffel et 
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aI, 1977) and has been attributed to early intervention with intensive care and plasmapheresis 
(Hughes 1990c, McKhann 1990). 
HlV infection was associated with GBS in the Tanzanian series and this agrees with the results 
of a similar study from Zimbabwe (Thorton et aI, 1991). GBS is amongst the earliest 
neurological disorders encountered in HIV disease in Africa (ConI on 1989, Thomton et aI, 
1991, Chinyanga and Dunha 1992). In the West descriptions ofGBS in HlV disease have been 
mainly in association with seroconversion after primary infection (Comblath et aI, 1987, Millar 
et aI, 1988). It is unlikely, however, that studies in Africa will reveal an association with 
seroconversion as primary HlV infection is only rarely reported there, despite the pandemic. 
There was no evidence of an association between HlV infection and GBS in Norway, where the 
overall seroprevalence ofHlV infection is particularly low. 
In our study the clinical features and course of GBS were more severe in the HlV seropositives 
than in the HIV seronegatives. This was evidenced by the shortened duration of onset, increased 
neurological involvement, higher CSF protein levels and the higher complication and mortality 
rate in the HlV seropositives. These findings are in contrast to those reported in Zimbabwe 
where no major clinical differences between HlV seropositives and seronegatives were found 
(Thomton et aI, 1991). While the findings in the Zimbabwian study agrees with what is 
generally the case concerning GBS in HIV disease a more rapid and fulminating course has also 
been reported in the West (Dalakas and Pezeshkpour 1988) and in some cases in Africa (Conlon 
1989, Chinyanga and Dunha 92). Although the level of immunodeficiency is likely to be critical 
for the clinical course further research is needed in order to assess the presentation and natural 
history of GBS in HIV disease. 
7.4. Konzo. 
The present studies on konzo in Tanzania provide detailed clinical, epidemiological and 
neurophysiological information on this dramatic disease. Several other epidemics of konzo have 
been reported from countries in Africa during the last decade. These include Mozambique 
(Ministry of Health Mozambique 1984a, 1984b, Essers et al, 1992, Davis and Howarth 1993), 
Zaire, (Tylleskar et ai, 1991, Banea et ai, 1992), Southern Tanzania (Mlingi et ai, 1991) and 
Central African Republic (Tylleskar et ai, 1994a). The combined evidence from Tanzanian and 
the other studies in Africa is now sufficiently strong to confirm that konzo represents a new and 
distinct human disease entity. 
Epidemiology. 
The most striking feature OF all studies on konzo is the uniformity of epidemiological and 
clinical findings. The prevalence ofkonzo in the Tanzanian villages ranged from 1-14 per 1000 
(paper V), as compared to 1-30/1000 in Zaire (Tylleskar et aI, 1991) and 0.1-2911000 in 
Mozambique (Ministry of Health 1984a). The highest dry season incidence rate in an epidemic 
of konzo to date 2911 000 was recorded in Mozambique. It is noteworthy that in all affected 
communities konzo causes more paralysis than all other neurological disorders including polio 
(paper V). The mean age of patients with konzo in Tanzania (paper IV) was 13 years (range 4-
46 years) and this agrees with other studies. There was sparing of breast fed children and adults 
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greater than 50 years in all studies. The male to female ratio was increased in Tanzania and 
Mozambique, but this was reversed in Zaire, suggesting that local factors can influence the sex 
ratio (Ministry of Health Mozambique 1984a, Tylleskar et ai, 1991). There was a pronounced 
tendency for family clustering in the Tanzanian and all other studies which could be explained 
by shared environmental exposure, genetic predisposition or, alternately, by an infectious 
aetiology. However there was no evidence of infection in the in any studies to date. A history of 
recurrence of aggravating episodes, in this and other studies may also be related to 
environmental factors. 
The temporal distribution of konzo in Tanzania also follows a characteristic pattern seen in 
other epidemics with the major outbreaks following drought. In the case of Zaire the epidemic 
did not coincide with drought but appeared to occur in conjunction with a chain of recurring 
stressful agroeconomic events reSUlting in the same type of food insecurity (Tylleskar et ai, 
1991). In that study, the building of a main road in the area allowed access to new markets 
which in turn led to intensive sales and a shortening of the processing method. The start of the 
epidemic in Tanzania was heralded by the occurrence of cases during the dry months. This was 
then followed by a dramatic increase over a 2-3 month period extending into the rainy season 
and then followed by a steep decline and cessation of cases (papers IV,v). A similar pattern was 
reported in Mozambique except that the epidemic there occurred exclusively in the dry season. 
In Zaire the epidemic occurred over a greater number of months during the dry season and the 
first part of the rainy season. Endemicity is seen in all studies with a small number of cases 
occurring during the non epidemic years. Endemic cases also follow a seasonal pattern similar 
to that of the epidemics. The pronounced geographic limitation of konzo was also the same in 
every epidemic. Konzo only affects poor rural populations in cassava growing areas of Africa 
whose diet during the preceding months consists almost exclusively bitter cassava roots. To 
date, no case of konzo has been reported from the nearby urban populations and similar to 
Mozambique the epidemic in Tanzania completely spared the mainly cassava eating populations 
in adjacent fishing villages. 
Clinical features. 
The clinical findings in konzo are also similar in all studies. (Trolli 1938, Lucasse 1952, 
Ministry of Health Mozambique 1984b, Carton et ai, 1986, Papers IV, V). There are no 
prodromata or triggering illnesses reported in konzo. In Tanzania the onset was characterized by 
an abrupt isolated paraparesis occurring within minutes or hours. A typical history was of 
sudden onset of weakness in the legs after prolonged exercise or on waking in the morning. A 
slower onset with progression over 2-3 days occurred in some cases or more rarely over a week. 
This was also reported in Mozambique (Ministry of Health 1984a). The main symptoms at 
onset were heaviness, trembling or weakness of the legs associated with difficulty or inability to 
stand. Other complaints at onset in more severe cases included generalized body weakness, 
weakness in the arms and hands, difficulty in articulating speech and blurring of vision and 
sensory symptoms including radicular low back pain and paraesthesia in the legs. These 
symptoms tended to clear during the first weeks or months in all but the most severely affected 
cases (Banea 1992). There was no evidence of autonomic or sphincteric involvement in this or 
other studies. 
On neurological examination the characteristic finding in every patient was of symmetrical 
spastic paraparesis which varied in severity from isolated hyperreflexia in mild cases to almost 
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complete paralysis of the legs in severe cases. The muscle weakness invariably affected the 
extensor muscle groups to a greater degree than the corresponding flexors (paper IV). The arms 
in konzo may be similarly involved but always to a much lesser extent than the legs. 
Hyperreflexia in the arms was present in over half the cases in Tanzania and Mozambique 
(Ministry of Health Mozambique 1984a). Any associated loss of power in the arms was 
generally mild and limited mainly to the extensors of the wrist, except in severe cases when it 
was more extensive. A postural thoracolumbar kyphosis related to weakness of the lower trunk 
muscles was evident in about a third of the patients in the Tanzania study. 
There were some minor clinical differences between the Tanzanian and the other main studies. 
Extensor plantar responses were not found in the Mozambique (Ministry of Health 1984b) and 
the original Zairian study (Trolli 1936), but were present in 85% in the Tanzanian study. This 
was most probably a correct fmding as they were shown to be present in most konzo patients in 
subsequent studies (Papers V,VI and Carton et aI, 1986). This difference may have been caused 
by technical difficulties in eliciting reflexes in heavily calloused feet as it was found necessary 
in the Tanzanian study to lie the patients flat and relax the legs muscles during the neurological 
examination in order to elicit a clear response. Sensation appears to be normal in konzo in this 
and other studies. Slight sensory impairment was found in a few patients in Mozambique, but 
this cleared later on (Ministry of Health Mozambique 1984b) and detailed peripheral nerve 
conduction studies showed no evidence of any peripheral neuropathy in the Tanzanian study 
(paper VI). There was no evidence of cerebellar involvement in konzo in the Tanzanian or any 
other study. The finding of impaired rapid alternating hand and eye movements in some patients 
in the Tanzanian study may be explained by associated muscle weakness. Isolated nystagmus 
was reported in two patients in Zaire (Tyleskar et ai, 1991) but may have another origin as it has 
not been reported in other studies. 
The cranial nerves may be involved in a small number of konzo patients. Symptoms and signs 
suggestive of optic neuritis, occurred in about 10% of acute cases in the Tanzanian study (paper 
IV), however, all patients were able to count fingers at one meter and symptoms cleared in the 
first few months in all patients. Persistent optic pallor was noted in two severe cases. Visual 
acuity was also normal in two Tanzanian patients with severe konzo when tested in Sweden, 
despite persistent signs of optic neuritis in one with a past history of visual problems (paper VI). 
Hearing difficulties are probably not a feature of konzo, or may be relatively rare. Although 
they were present in lout of 53 Mozambique cases (Ministry of Health 1984b) and in 2 out of 
20 Zairian cases (Carton et ai, 1986) they were absent altogether in the Tanzanian studies. 
Difficulty in speaking or persistent nasal voice is common in the acute phase in all studies but 
persists in only the most severe cases. The origin of this is unclear, although it is generally 
considered to be most likely suprabulbar in origin. The finding of an impaired gag reflex in two 
dysarthric patients in Tanzania (paper IV) would appear to contradict this, but this finding was 
present in only 5% of cases examined under field conditions. Intellectual and mental capacity 
appear to be normal in konzo. 
Konzo is therefore characterized by isolated, symmetrical, permanent but non progressive 
damage to the upper motor neurones varying only in severity and always bilaterally affecting 
the distal order neurones to a greater extent than the proximal ones. The permanent clinical 
features are spastic paraparesis, scissors gait, flexion and adduction deformities at the hips and 
knees, valgus ankle deformity with plantar flexion and inversion of the feet and abduction of the 
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forefoot and toes. Functional involvement of the arms and cranial nerves occurs in the more 
severe cases. 
Course and prognosis. 
There was an improvement in the level of disability in konzo in Tanzania during the first weeks 
or months after the onset of the disease (paper IV). Most patients were then able to stand or 
crawl or walk with assistance. This is also reported in other studies. Very mild cases may appear 
clinically nonnal at this stage except for the presence of disability visible only on running, or 
the finding of hyperreflexia on neurological examination. However, in all other cases the 
underlying spastic paraparesis remains unchanged for life. This impression was confmned in 
Tanzania (paper V) where 96% of patients reviewed 4 years after onset reported no long tenn 
improvement. 
Konzo typically presents in sharply limited geographical foci in Africa. During the epidemic in 
Tanzania only the first two patients were referred to the local mission hospital after which all 
patients were cared for at home by their extended families. These were then involved in locally 
initiated rehabilitation programs lasting many months with traditional healers and using home 
made walking aids and sticks. Children with mild or moderate disabilities subsequently 
continued to attend school while some of those with more severe disabilities developed a 
sedentary trade eg, shoemaker. The majority of konzo patients continue to live a relatively 
nonnallife despite their disabilities that put a considerable extra burden on their families. Some 
konzo patients of both sexes are known to marry and have healthy children. 
The most serious long tenn consequence of konzo is an increased mortality rate. This has been 
observed in all study areas, including Tanzania. In Zaire, a mortality rate of over 20% was 
recorded 1-7 years after onset occurring particularly in severe cases and in males (Tylleskar et 
ai, 1991). Individual konzo deaths have been attributed to malnutrition and infection. Flexion 
contractures around the ankle and knee are also long tenn complications (paper V). There was a 
dramatic improvement in mobility after surgery in two konzo patients who were operated on by 
an Italian surgeon for contractures (Tylleskar et ai, 1994). This suggests that increased muscle 
spasm and secondary contractures may contribute significantly to the disability in konzo. 
Differential diagnosis. 
The use of simple diagnostic criteria (Tylleskar et ai, 1991, paper V) suggests that in its 
epidemic fonn konzo can be easily diagnosed by medical and lay persons alike. While the 
unifonn findings in konzo also help distinguish it from the other main causes of paraplegia, a 
more detailed neurological evaluation by a physician may be necessary in order to distinguish it 
from the other types of tropical myeloneuropathies. These differences are summarized in Table 
1. 
Lathyrism is the paraparesis which is most similar to konzo and if the two diseases were to 
occur in the same geographic area it would be clinically almost impossible to distinguish one 
from another. It is possible, however, to distinguish konzo from lathyrism simply because there 
is no chick pea grown or consumed in areas affected by konzo. Hence, konzo and lathyrism 
have not yet been reported in the same populations. There are however some minor clinical 
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differences between lathyrism and konzo (Ludolph et aI, 1987). Firstly, the onset of lathyrism is 
mainly in the second and third decade, an older age than konzo. Secondly, sphincteric 
disturbance, although rare in lathyrism, are absent in konzo and, thirdly, there is no optic 
neuritis in lathyrism whereas it can occur in konzo. 
Konzo and HTLVl associated myelopathy (HAM) can also be distinguished clinically from one 
another. The onset of HAM is typically slow and its course progressive over months or years 
whereas the onset of konzo is acute and its course non progressive. HAM is endemic worldwide 
with relatively low prevalence rates of around 0.1 % and also occurs in urban areas whereas 
konzo is epidemic, restricted to cassava growing areas in rural Africa and has much higher 
prevalence rates, up to 3%. The mean age at onset of HAM is the fourth and fifth decade, 
whereas konzo affects mainly children above the age of three. There are also some clinical 
differences. Peripheral neuropathy, sensory dysesthesia on the trunk and sphincteric 
disturbances are all clinical features of HAM, but these are all absent in konzo. The cranial 
nerves are usually normal in HAM but may be involved in konzo. Finally HAM is caused by a 
chronic neurotropic virus, HTL V -1 infection whereas evidence of HTL V -1 infection is absent 
in konzo. 
Tropical ataxic neuropathy (TAN) is the tropical myeloneuropathy (Osuntokun 1981) which is 
most often confused with konzo. The main reason is that they both have been attributed to 
dietary cyanide exposure from the consumption of insufficiently processed cassava. There are, 
however, a number of epidemiological and clinical features which distinguish TAN from konzo. 
TAN occurs endemically whereas konzo is mainly epidemic. Also interestingly they have not 
been reported occurring together in the same population. The onset of TAN is typically gradual, 
over months or years and its course is progressive. This is in sharp contrast to konzo whose 
onset is abrupt, within minutes or hours, and its course non progressive. The mean age group 
affected in TAN is greater than forty years, whereas konzo has a predilection for children and 
females in the fertile age group. However the major difference between these two disorders is 
clinical. Ataxia, sensory neuropathy and deafness which are the clinical features of TAN are 
absent in konzo. Optic neuritis is common in TAN whereas in konzo it is relatively uncommon. 
Spastic paraparesis only affects only about 20% of patients with TAN whereas it is present in all 
konzo cases. 
The dietary observations in this study support the hypothesis that the etiology of konzo is linked 
with exclusive consumption of insufficiently processed cassava. A clear temporal relationship 
was seen between the first occurrence of konzo in Tarime district and the introduction in 1979 
of the more high yielding toxic varieties of cassava (paper V). The cassava processing method 
reported in Tarime (paper IV) had not been described before, and may be ineffective in 
removing cyanogenic substances since root disintegration is incomplete (Essers et aI, 1992). 
The removal of cyanogens may have been still more ineffective because of shortening of 
processing due to food shortages (Lancaster et aI, 1982). The association between exposure to a 
dietary cyanide and konzo is supported by the high serum thiocyanate level found in cases in 
Tanzania that correspond to levels in konzo reported from Mozambique and Zaire (Ministry of 
Health 1984a, Tylleskar et aI, 1991). These levels are in fact amongst the highest recorded in 
cassava eating populations and are up to eight times higher than in a reference popUlation 
(Lundquist 1982). There was also a pronounced seasonal variation of cyanide exposure in the 
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konzo affected populations in Tanzania and Mozambique. This was measured as decreasing 
thiocyanate levels which coincided with the end of the epidemic. 
Konzo completely spared the cassava consuming lake shore villages in Tanzania where they 
had greater fish consumption, and also the adjacent town where they had other commercially 
available food. In contrast there was almost a complete absence of supplementary food and 
dietary protein in the konzo affected inland villages (paper V). This pattern was identical to that 
seen in Mozambique where a high dietary cyanide in combination with low protein, in 
particular sulphur based amino acids, has been postulated as a possible mechanism for konzo 
(Cliff et ai, 1985). An attempt was made to exclude other possible dietary causes in Tanzania. 
Lathyrus sativus was not grown in the area and there was no evidence of widespread 
consumption of wild plants or use of pesticides. 
An infectious agent was initially suspected in the Tanzanian and the other konzo epidemics 
(Carton et ai, 1985) but no laboratory evidence of HTLVl or any other infectious agent was 
found in this or any of the other studies. The results of extensive laboratory and 
neurophysiological investigations carried out in Sweden on two Tanzanian konzo patients were 
essentially normal (paper VI) with the exception of the magnetic brain stimulation. This result, 
however, was highly abnormal showing no visible contraction in the legs or in the less affected 
arms in response to maximum stimulation. This fmding suggests that the site of pathology in 
konzo is situated centrally in the motor cortex rather than in the spinal cord. A similar pattern of 
response has been reported in other neurological diseases with known central sites of pathology 
including motor neurone disease (Hugon et ai, 1987). The lack of response in the arms was a 
somewhat surprising result given the relatively small amount of clinical involvement as 
compared to the legs. This suggests subclinical damage to a subpopulation of central motor 
neurones serving arm function. Evidence to support subclinical involvement in konzo comes 
from the finding of isolated increased ankle reflexes in asymptomatic healthy school children in 
affected communities (Cliff et ai, 1986, personal observation). 
Possible pathogenic mechanisms. 
Cyanide exposure can result in damage to the nervous system, but the type of damage attributed 
to cyanide appears to depend on dosage, duration and possibly other associated dietary factors. 
Acute, fatal cyanide intoxications are uncommon, but well known in cassava eating populations 
worldwide, and have also been reported in Tanzania (Mlingi et ai, 1992). Basal ganglia damage 
with subsequent parkinsonian features can result from sublethal acute cyanide exposure (Carella 
1988). Central and peripheral nervous system damage has been associated with moderate 
cyanide exposure over years possibly in combination with vitamin deficiency as occurs in TAN 
(Osuntokun 1981). There is also laboratory evidence that chronic high dose cyanate, a cyanide 
metabolite, exposure in primates can induce a konzo like disease, and of particular interest is the 
fact that only minor histological changes were noted in the cortico-spinal tracts of those 
primates (Shaw et ai, 1974). The pathogenic mechanism of konzo is not known and the causal 
role for cyanide is not proven beyond doubt. However the evidence is sufficiently strong to 
assume that konzo results from abrupt irreversible selective upper motor neurone cell damage or 
cell death arising after weeks or months of uninterrupted exposure to dietary cyanide without 
adequate protein or other factors necessary for cyanide metabolism. Verification of the etiology 
ofkonzo is probably possible with animal models. 
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While understanding the pathogenic mechanisms of konzo is clearly of much importance in 
itself and may also help in elucidating the mechanism of cell damage in other forms of upper 
motor neurone disease, the public health aspects are more important. There is now enough 
evidence to prevent konzo by promoting effective processing methods and ensuring adequate 
supplies of supplementary foods. 
CONCLUSIONS 
HIV: Focal neurological disorders (10%), cognitive impairment (19%) and associated abnormal 
neurological findings (70%) were major clinical findings in patients with mainly advanced 
AIDS from northern Tanzania. The neurological findings were generally similar to those 
reported in AIDS in the West. The SR and PMR were the most frequent abnormal neurological 
finding occurring terminally in three out of every four AIDS patients. The frequency of SR and 
PMR increased incrementally with advancing HIV stage and associated neurological findings, 
from asymptomatic HIV infection to terminal AIDS. 
GBS: Comparing a series of GBS patients from northern Tanzania with GBS patients in 
Western Norway, the incidence rate, epidemiological and main findings, apart from some minor 
clinical differences, were similar in the two series. The significantly increased mortality rate 
(15%) seen in the Tanzanian series is probably explained by the lack of resources for adequate 
intensive medical care. An association between HIV infection and GBS was seen in the 
Tanzanian, but not the Norwegian series. HIV positive GBS patients tended to have more severe 
neurological disease and increased mortality. 
Konzo: Konzo represents a new disease entity which can be distinguished clinically from the 
other main forms of tropical myeloneuropathies. In its epidemic form it is the single most 
important cause of paralysis in affected communities. The aetiology ofkonzo is most probably a 
toxic effect arising from some months of ingestion of cyanogenic compounds from 
insufficiently processed cassava under adverse dietary conditions. The site of the pathology in 
konzo is most probably in the motor cortex rather than in the spinal cord. 
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Fig 2_ Family of five children who developed konzo within one week_ 
Table 1. Characteristic features of four tropical rnyeloneuropathies. 
Konzo Tropical Lathyrism HTLV-J 
ataxic associated 
neuropathy myelopathy 
Geographical area Africa Africa Asia & Africa Worldwide 
Occurrence Epidemic Endemic Epidemic Endemic 
Highest prevalence 3% 3% 3% 0.1% 
Familial clustering Yes Yes Yes Yes 
Type of onset Acute Slow Acute Slow 
Course Permanent Progressive Permanent Progressive 
High incidence agegroup < 40 > 40 < 40 > 40 
MAIN NEUROLOGICAL FINDINGS: 
Gait abnormality Spastic Ataxia Spastic Spastic 
paraparesis paraparesis paraparesis 
Peripberal neuropathy No Yes No Common 
Sphincter involvement No No Rare Yes 
Optic atrophy Rare Yes No No 
Dealness No Common No No 
AETIOLOGY: Attributed to Attributed to Caused by Caused by 
weeks of years of weeks of chronic 
high cyanide varying cyanide high lathyrus HTLV-1 
exposure exposure consumption infection 
from cassava from cassava 
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Figure 1. Map of Tanzania with the study sites indicated. 
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